ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Nexavar Improves PFS In Phase III Trial

January 25, 2013

New Tool Found To Cut DNA At Any Position

April 4, 1986

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976

To Industry for Development, NDA

November 18, 1977